Healthcare
FNArena Windows (Sectors)
Introduction to FNArena Windows
FNArena Windows offers subscribers the option to investigate ASX-listed stocks against their peers. FNArena developed its own sector methodology which in our view overcomes many flaws and disadvantages connected with GICS sectors. Our system starts with three broad sector labels: COMMODITIES, FINANCIAL SERVICES and INDUSTRIALS. From here onwards subscribers can explore further through gradually narrowing branches. This is not investment advice, but simply another window on the Australian Stock Exchange to provide better insight and to assist FNArena subscribers while conducting their own market analysis.
Latest Stories
Uncertain Behring growth, lower vaccine sales and a controversial restructuring plan led to a post-result share price drubbing. Is it all over for CSL?
Aug 21 2025
Following a weak FY25, and weak FY26 guidance, Cochlear’s outlook rests on the success of its new Nexa implant and other products. Is the market too confident?
Aug 19 2025
| ASX CODE | COMPANY NAME | LAST PRICE | 52WK HIGH | 52WK LOW | P/E | CONSENSUS TARGET |
|---|---|---|---|---|---|---|
| 4DX | $1.78 | $2.38 | $0.23 |
$0.905 |
||
| ACL | $2.55 | $3.86 | $2.47 |
$3.20 |
||
| ALC | $0.09 | $0.14 | $0.05 |
$0.13 |
||
| ARX | AROA BIOSURGERY LIMITED | $0.69 | $0.82 | $0.35 | 68.8 |
$0.81 |
| AVH | AVITA MEDICAL INC | $1.48 | $4.52 | $1.27 |
$1.75 |
|
| BIO | $0.47 | $xx.xx | $xx.xx | xx.x | xx.xx | |
| BMT | $0.22 | $xx.xx | $xx.xx | xx.x | xx.xx | |
| CAT | CATAPULT SPORTS LIMITED | $6.79 | $xx.xx | $xx.xx | xx.x | xx.xx |
| COH | COCHLEAR LIMITED | $302.72 | $xx.xx | $xx.xx | xx.x | xx.xx |
| CSL | CSL LIMITED | $204.48 | $xx.xx | $xx.xx | xx.x | xx.xx |
| CU6 | $3.23 | $xx.xx | $xx.xx | xx.x | xx.xx | |
| CUV | $10.80 | $xx.xx | $xx.xx | xx.x | xx.xx | |
| CVB | CURVEBEAM AI LIMITED | $0.12 | $xx.xx | $xx.xx | xx.x | xx.xx |
| CYC | CYCLOPHARM LIMITED | $0.89 | $xx.xx | $xx.xx | xx.x | xx.xx |
| DOC | DOCTOR CARE ANYWHERE GROUP PLC | $0.21 | $xx.xx | $xx.xx | xx.x | xx.xx |
| EBO | EBOS GROUP LIMITED | $25.89 | $xx.xx | $xx.xx | xx.x | xx.xx |
| EBR | EBR SYSTEMS INC | $1.17 | $xx.xx | $xx.xx | xx.x | xx.xx |
| EGH | $0.52 | $xx.xx | $xx.xx | xx.x | xx.xx | |
| EMV | $2.32 | $xx.xx | $xx.xx | xx.x | xx.xx | |
| FPH | FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED | $33.79 | $xx.xx | $xx.xx | xx.x | xx.xx |
| GSS | $0.28 | $xx.xx | $xx.xx | xx.x | xx.xx | |
| HLS | HEALIUS LIMITED | $0.80 | $xx.xx | $xx.xx | xx.x | xx.xx |
| IDX | INTEGRAL DIAGNOSTICS LIMITED | $2.89 | $xx.xx | $xx.xx | xx.x | xx.xx |
| IME | IMEXHS LIMITED | $0.26 | $xx.xx | $xx.xx | xx.x | xx.xx |
| IMM | IMMUTEP LIMITED | $0.26 | $xx.xx | $xx.xx | xx.x | xx.xx |
| IMR | IMRICOR MEDICAL SYSTEMS INC | $1.39 | $xx.xx | $xx.xx | xx.x | xx.xx |
| INA | INGENIA COMMUNITIES GROUP | $5.63 | $xx.xx | $xx.xx | xx.x | xx.xx |
| IPD | IMPEDIMED LIMITED | $0.04 | $xx.xx | $xx.xx | xx.x | xx.xx |
| LIC | $5.97 | $xx.xx | $xx.xx | xx.x | xx.xx | |
| M7T | MACH7 TECHNOLOGIES LIMITED | $0.30 | $xx.xx | $xx.xx | xx.x | xx.xx |
| MAP | $0.08 | $xx.xx | $xx.xx | xx.x | xx.xx | |
| MDR | MEDADVISOR LIMITED | $0.04 | $xx.xx | $xx.xx | xx.x | xx.xx |
| MPL | MEDIBANK PRIVATE LIMITED | $4.86 | $xx.xx | $xx.xx | xx.x | xx.xx |
| MSB | MESOBLAST LIMITED | $2.32 | $xx.xx | $xx.xx | xx.x | xx.xx |
| MVF | MONASH IVF GROUP LIMITED | $0.68 | $xx.xx | $xx.xx | xx.x | xx.xx |
| MVP | $0.60 | $xx.xx | $xx.xx | xx.x | xx.xx | |
| MX1 | MICRO-X LIMITED | $0.09 | $xx.xx | $xx.xx | xx.x | xx.xx |
| NAN | NANOSONICS LIMITED | $4.05 | $xx.xx | $xx.xx | xx.x | xx.xx |
| NEU | NEUREN PHARMACEUTICALS LIMITED | $19.35 | $xx.xx | $xx.xx | xx.x | xx.xx |
| NHF | NIB HOLDINGS LIMITED | $7.59 | $xx.xx | $xx.xx | xx.x | xx.xx |
| NUZ | $0.14 | $xx.xx | $xx.xx | xx.x | xx.xx | |
| ONE | ONEVIEW HEALTHCARE PLC | $0.23 | $xx.xx | $xx.xx | xx.x | xx.xx |
| OPT | $0.60 | $xx.xx | $xx.xx | xx.x | xx.xx | |
| PAR | $0.27 | $xx.xx | $xx.xx | xx.x | xx.xx | |
| PGC | PARAGON CARE LIMITED | $0.33 | $xx.xx | $xx.xx | xx.x | xx.xx |
| PME | $294.14 | $xx.xx | $xx.xx | xx.x | xx.xx | |
| PNV | POLYNOVO LIMITED | $1.53 | $xx.xx | $xx.xx | xx.x | xx.xx |
| PYC | PYC THERAPEUTICS LIMITED | $1.22 | $xx.xx | $xx.xx | xx.x | xx.xx |
| REG | $8.73 | $xx.xx | $xx.xx | xx.x | xx.xx | |
| RHC | RAMSAY HEALTH CARE LIMITED | $33.74 | $xx.xx | $xx.xx | xx.x | xx.xx |
| RMD | RESMED INC | $40.68 | $xx.xx | $xx.xx | xx.x | xx.xx |
| SHL | SONIC HEALTHCARE LIMITED | $22.52 | $xx.xx | $xx.xx | xx.x | xx.xx |
| SNT | $0.03 | $xx.xx | $xx.xx | xx.x | xx.xx | |
| SOM | SOMNOMED LIMITED | $0.73 | $xx.xx | $xx.xx | xx.x | xx.xx |
| TLX | TELIX PHARMACEUTICALS LIMITED | $14.00 | $xx.xx | $xx.xx | xx.x | xx.xx |
| TRJ | $0.74 | $xx.xx | $xx.xx | xx.x | xx.xx |
Previous Stories
ResMed’s New Level Of Support
Jul 29 2025
Michael Gable of Fairmont Equities reports buying the dip remains a valid strategy for ResMed shares above new technical support of $40
Healthcare’s Challenge: Antimicrobial Resistance
Jul 23 2025
Surging Antimicrobial resistance is expected to cost US$3bn to US$4bn over the next decade and lower GDP of low-and middle-income countries, Federated Hermes warns
Renewed Momentum For CSL Shares
Jul 22 2025
Michael Gable of Fairmont Equities suggests CSL shares have found a bottom and seem destined for $300-plus yet again
Treasure Chest: CSL Not A One-Trick Pony
Jul 14 2025
FNArena’s Treasure Chest reports on money making ideas from stockbrokers and other experts. Today’s idea is on CSL
Strength To ‘AI’ Strength For Pro Medicus
Jul 10 2025
Pro Medicus shares surge on major contract wins and growing AI momentum, reinforcing its position as a high-margin healthcare tech leader against a background of eternal valuation debate
The Enigma Surrounding Clinuvel
Jul 03 2025
Clinuvel Pharmaceuticals posted a strong first half result, and offers significant upside in expanding the use of its flagship drug, but investors just aren’t excited
Better Times Ahead For Sonic Healthcare?
Jun 20 2025
New research coverage on Sonic Healthcare suggests better times are ahead, supplemented by new technologies including artificial intelligence and genetic engineering
Cochlear Downgrades Ahead Of New Launches
Jun 19 2025
A decline in Services revenue had led to another profit downgrade from Cochlear, but brokers look ahead to new product launches
Fisher & Paykel Healthcare’s Tariffs Annoyance
Jun 04 2025
A consensus-beating FY25 result from Fisher & Paykel Healthcare was undermined by disappointing FY26 guidance, with tariffs partly to blame
Rudi’s View: CSL & NextDC
May 08 2025
Your Editor attended presentations by CSL and NextDC this week
Latest News
| 1 |
The Overnight Report: Gold & Big Tech Soar8:39 AM - Daily Market Reports |
| 2 |
Today’s Financial Calendar – 16-09-20258:15 AM - Daily Market Reports |
| 3 |
ASX Winners And Losers Of Today – 15-09-25Sep 15 2025 - Daily Market Reports |
| 4 |
Australian Listed Real Estate Tables – 15-09-2025Sep 15 2025 - Weekly Reports |
| 5 |
The Great LIC And LIT Discount Dilemma – A Structural ReckoningSep 15 2025 - Australia |